Form 4 for CDNA CareDx, Inc.
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-21 · accession 0002036499-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | 2025-03-21 | CDNA | Meng Jessica | Chief Commercial Off | A - Grant | $0.00 | +61.8K | 114.3K | +117% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-21 | A | A | 61,756 | $0.00 | 114,332 | D | — | — | (F1) The reported securities are represented by restricted stock units, of which one-third will vest on April 1, 2026 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the restricted stock units will be vested on the third anniversary of April 1, 2026, subject to the Reporting Person's continuous employment on each applicable vesting date. |